MEDIA ADVISORY: PCORI Board to Consider Hepatitis C and PCORnet Phase II Funding at Dec. 8 Meeting

The Board of Governors of the Patient-Centered Outcomes Research Institute (PCORI) will consider whether to approve funding for comparative clinical effectiveness research on hepatitis C virus infection at its meeting on Monday, Dec. 8 in Washington, DC.

In addition, the Board will vote on a plan to fund the second phase of development of PCORnet, PCORI’s initiative to improve the efficiency of health research by harnessing information from electronic health records (EHRs) and other resources.

The meeting will run from 10:15 a.m. to 5:45 p.m. EST Monday, Dec. 8, at the Renaissance Dupont Circle Hotel, 1143 New Hampshire Ave., NW, Washington, DC. The public may attend in person or via teleconference/webinar. Visit the meeting page to view the agenda and register to join the teleconference/webinar.